Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Covington
McKinsey
Farmers Insurance
Johnson and Johnson
US Army
Argus Health
Cipla

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090416

« Back to Dashboard

NDA 090416 describes MOEXIPRIL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Generics, Teva, Glenmark Pharms, and Heritage Pharms Inc, and is included in eight NDAs. It is available from five suppliers. Additional details are available on the MOEXIPRIL HYDROCHLORIDE profile page.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
Summary for 090416
Tradename:MOEXIPRIL HYDROCHLORIDE
Applicant:Glenmark Generics
Ingredient:moexipril hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 090416
Suppliers and Packaging for NDA: 090416
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416 ANDA Glenmark Pharmaceuticals Inc., USA 68462-208 N 68462-208-01
MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416 ANDA Glenmark Pharmaceuticals Inc., USA 68462-208 N 68462-208-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Mar 30, 2010TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Mar 30, 2010TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Harvard Business School
Dow
Cantor Fitzgerald
Argus Health
UBS
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.